Oireachtas Joint and Select Committees

Wednesday, 6 March 2019

Joint Oireachtas Committee on Health

National Medicines Strategy: Discussion

Dr. Kieran Harkin:

Yes. There is an over-reliance on the brand leader and limited clinical evidence for that. That should change and I see Dr. Barry from the NCPE has said he will go about doing that.

Comments

No comments

Log in or join to post a public comment.